Orthopaedic Trauma-Induced Pyoderma Gangrenosum: A Case Report.
Journal
JBJS case connector
ISSN: 2160-3251
Titre abrégé: JBJS Case Connect
Pays: United States
ID NLM: 101596828
Informations de publication
Date de publication:
Historique:
entrez:
11
7
2020
pubmed:
11
7
2020
medline:
5
2
2021
Statut:
ppublish
Résumé
We present a case of a 60-year-old polytraumatized man who developed postoperative pyoderma gangrenosum (PG) after his initial stabilization procedures, mimicking a postoperative infection. This caused a delay in diagnosis, leading to progression of his wounds and a delay in initiation of the appropriate treatment. Once his PG was appropriately treated, his clinical status and wounds improved. He underwent successful wound coverage by plastic surgery and has been recovering from his injuries. Prompt identification and initiation of treatment for postoperative PG is critical to avoid exacerbation of wounds and subsequent morbidity to the patient.
Identifiants
pubmed: 32649133
doi: 10.2106/JBJS.CC.19.00562
pii: 01709767-202006000-00052
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0562Références
Alavi A, French LE, Davis MD, Brassard A, Kirsner RS. Pyoderma gangrenosum: an update on pathophysiology, diagnosis and treatment. Am J Clin Dermatol. 2017;18:355-72.
Binus AM, Qureshi AA, Li VW, Winterfield LS. Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients. Br J Dermatol. 2011;165(6):1244-50.
Zuo KJ, Fung E, Tredget EE, Lin A. A systemic review of postsurgical pyoderma gangrenosum: identification of risk factors and proposed management strategy. J Plast Reconstr Aesthet Surg. 2015;68:295-303.
Tolkachjov SN, Fahy AS, Wetter DA, Brough KR, Bridges AG, Davis MD, El-Azhary RA, McEvoy MT, Camilleri MJ. Postoperative pyoderma gangrenosum (PG): the Mayo Clinic experience of 20 years from 1994 through 2014. J Am Acad Dermatol. 2015;73:615-22.
Su WP, Davis MD, Weenig RH, Powell FC, Perry HO. Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria. Int J Dermatol. 2004;43:790-800.
Schatzker J, McBroom R, Bruce D. The tibial plateau fracture: the Toronto experience: 1968-1975. Clin Orthop Relat Res. 1979;138:94-104.
Gustilo RB, Anderson JT. Prevention of infection in the treatment of one thousand and twenty-five open fracture of long bones: retrospective and prospective analyses. J Bone Joint Surg Am. 1976;58:453-8B
Meinberg E, Agel J, Roberts C, Karam MD, Kellam JF. Fracture and Dislocation Classification Compendium-2018. J Orthop Trauma. 2018;32(suppl 1):S1-170.
Chapman S, Delgadillo D, Rispler D. Pyoderma gangrenosum: a review of orthopedic case reports. J Dermatol Res Ther. 2016;2:018.
Partridge ACR, Bai JW, Rosen CF, Walsh SR, Gulliver WP, Fleming P. Effectiveness of systemic treatments for pyoderma gangrenosum: a systematic review of observational studies and clinical trials. Br J Dermatol. 2018;179(2):290-5.
Patel F, Fitzmaurice S, Duong C, He Y, Fergus J, Raychaudhuri SP, Garcia MS, Maverakis E. Effective strategies for the management of pyoderma gangrenosum: a comprehensive review. Acta Derm Venereol. 2015;95(5):525-31.
Song H, Lahood N, Mostaghimi A. Intravenous immunoglobulin as adjunct therapy for refractory pyoderma gangrenosum: systematic review of cases and case series. Br J Dermatol. 2018;178(2):363-8.
Long CC, Jessop J, Young M, Holt PJ. Minimizing the risk of post-operative pyoderma gangrenosum. Br J Dermatol. 1992;127(1):45-8.